A Review of Behavioral Tests to Evaluate Different Types of Anxiety and Anti-anxiety Effects

Overview

Journal Clin Psychopharmacol Neurosci

Specialty Psychiatry

Date 2020 Jul 24

PMID 32702213

Citations 47

Authors

Deepa Sarkar

Affiliations

Soon will be listed here.

Abstract

Behavioral tests are very useful to understand the Neuro-psychotic disease and also helpful in finding the treatment of the particular disease. Nowadays various tests are available to evaluate the anxiolytics effect of a new entity or even for comparative studies with the standard drug. As per the ethics, a new compound or drug believes to have possible pharmacological effects should be tested on animals before tested on humans which have similar physiology than humans. First, rats were used for behavioral test for evaluation of anti-anxiety drug but later on the various strain of mice were added for evaluation of anxiolytics because of better genetic possibilities than rats. In this review article, we have discussed the most commonly used behavioral tests used to evaluate the anti-anxiety effect. Anxiolytics are the agent which are used to elevate anxiety effect produced due to any cause. The various parameter will be undertaken for the better and precise evaluation of anxiolytics.

Citing Articles

Chronic exposure to a synthetic cannabinoid improves cognition and increases locomotor activity in Tg4-42 Alzheimer's disease mice.

Ott F, Sichler M, Bouter C, Enayati M, Wiltfang J, Bayer T J Alzheimers Dis Rep. 2025; 9:25424823241306770.

PMID: 40034517 PMC: 11869267. DOI: 10.1177/25424823241306770.

L. Oligo-Polysaccharides (CIO) Exerts Antianxiety and Antidepressant Effects on Mice Experiencing Behavioral Despair and Chronic Unpredicted Mild Stress.

Luo Y, Bei X, Zhang Y, Sun X, Zhao Y, Chen F Foods. 2025; 14(1.

PMID: 39796425 PMC: 11720489. DOI: 10.3390/foods14010135.

Dietary methionine supplementation improves cognitive dysfunction associated with transsulfuration pathway upregulation in subacute aging mice.

Xu Y, Yang Y, Shi Y, Li B, Xie Y, Le G NPJ Sci Food. 2024; 8(1):104.

PMID: 39702349 PMC: 11659567. DOI: 10.1038/s41538-024-00348-w.

Curcumin and exercise prevent depression alleviating hippocampus injury and improve depressive-like behaviors in chronically stressed depression rats.

Ahmadi E, Pourmotabbed A, Aghaz N, Nedaei S, Veisi M, Salimi Z Res Pharm Sci. 2024; 19(5):509-519.

PMID: 39691296 PMC: 11648346. DOI: 10.4103/RPS.RPS_94_23.

Exercise-induced anxiety impairs local and systemic inflammatory response and glucose metabolism in C57BL/6J mice.

Galvez I, Navarro M, Torres-Piles S, Martin-Cordero L, Hinchado M, Ortega E Brain Behav Immun Health. 2024; 43:100910.

PMID: 39686921 PMC: 11648794. DOI: 10.1016/j.bbih.2024.100910.

References

Stanford S . The Open Field Test: reinventing the wheel. J Psychopharmacol. 2007; 21(2):134-5. DOI: 10.1177/0269881107073199. View

Labots M, van Lith H, Ohl F, Arndt S . The modified hole board--measuring behavior, cognition and social interaction in mice and rats. J Vis Exp. 2015; (98). PMC: 4541485. DOI: 10.3791/52529. View

Bourin M, Hascoet M . The mouse light/dark box test. Eur J Pharmacol. 2003; 463(1-3):55-65. DOI: 10.1016/s0014-2999(03)01274-3. View

Hascoet M, Bourin M, Nic Dhonnchadha B . The influence of buspirone, and its metabolite 1-PP, on the activity of paroxetine in the mouse light/dark paradigm and four plates test. Pharmacol Biochem Behav. 2000; 67(1):45-53. DOI: 10.1016/s0091-3057(00)00293-8. View

Bourin M . Animal models for screening anxiolytic-like drugs: a perspective. Dialogues Clin Neurosci. 2015; 17(3):295-303. PMC: 4610614. View

Walf A, Frye C . The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc. 2007; 2(2):322-8. PMC: 3623971. DOI: 10.1038/nprot.2007.44. View

Taylor G, Lerch S, Chourbaji S . Marble burying as compulsive behaviors in male and female mice. Acta Neurobiol Exp (Wars). 2017; 77(3):254-260. View

Fraser L, Brown R, Hussin A, Fontana M, Whittaker A, OLeary T . Measuring anxiety- and locomotion-related behaviours in mice: a new way of using old tests. Psychopharmacology (Berl). 2010; 211(1):99-112. DOI: 10.1007/s00213-010-1873-0. View

Rodgers R . Animal models of 'anxiety': where next?. Behav Pharmacol. 1998; 8(6-7):477-96; discussion 497-504. DOI: 10.1097/00008877-199711000-00003. View

10.

Zimcikova E, Simko J, Karesova I, Kremlacek J, Malakova J . Behavioral effects of antiepileptic drugs in rats: Are the effects on mood and behavior detectable in open-field test?. Seizure. 2017; 52:35-40. DOI: 10.1016/j.seizure.2017.09.015. View

11.

Thiels E, Hoffman E, Gorin M . A reliable behavioral assay for the assessment of sustained photophobia in mice. Curr Eye Res. 2008; 33(5):483-91. DOI: 10.1080/02713680802130347. View

12.

Ohl F, Sillaber I, Binder E, Keck M, Holsboer F . Differential analysis of behavior and diazepam-induced alterations in C57BL/6N and BALB/c mice using the modified hole board test. J Psychiatr Res. 2001; 35(3):147-54. DOI: 10.1016/s0022-3956(01)00017-6. View

13.

Wilks L, File S . Evidence for simultaneous anxiolytic and aversive effects several hours after administration of sodium phenobarbitone to the rat. Neuropsychobiology. 1988; 19(2):86-9. DOI: 10.1159/000118440. View

14.

Prut L, Belzung C . The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 2003; 463(1-3):3-33. DOI: 10.1016/s0014-2999(03)01272-x. View

15.

Czech D, Quock R . Nitrous oxide induces an anxiolytic-like effect in the conditioned defensive burying paradigm, which can be reversed with a benzodiazepine receptor blocker. Psychopharmacology (Berl). 1993; 113(2):211-6. DOI: 10.1007/BF02245699. View

16.

Bourin M, Redrobe J, Hascoet M, Baker G, Colombel M . A schematic representation of the psychopharmacological profile of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry. 1996; 20(8):1389-402. DOI: 10.1016/s0278-5846(96)00134-0. View

17.

Angoa-Perez M, Kane M, Briggs D, Francescutti D, Kuhn D . Marble burying and nestlet shredding as tests of repetitive, compulsive-like behaviors in mice. J Vis Exp. 2014; (82):50978. PMC: 4108161. DOI: 10.3791/50978. View

18.

Roedel A, Storch C, Holsboer F, Ohl F . Effects of light or dark phase testing on behavioural and cognitive performance in DBA mice. Lab Anim. 2006; 40(4):371-81. DOI: 10.1258/002367706778476343. View

19.

Hascoet M, Bourin M, Nic Dhonnchadha B . The mouse light-dark paradigm: a review. Prog Neuropsychopharmacol Biol Psychiatry. 2001; 25(1):141-66. DOI: 10.1016/s0278-5846(00)00151-2. View

20.

Lister R . The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl). 1987; 92(2):180-5. DOI: 10.1007/BF00177912. View